Double Vers Single in Cesarean Incision
Effect of Single Layer Versus Double Layer Suturing on Healing of Caesarean Uterine Scar: A Randomized Controlled Trial
1 other identifier
observational
60
1 country
1
Brief Summary
To assess the effect of single versus double layer closure of caesarean scar on the residual myometrium on the short \& intermediate term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2022
CompletedFirst Posted
Study publicly available on registry
March 11, 2022
CompletedStudy Start
First participant enrolled
April 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedAugust 16, 2022
August 1, 2022
6 months
March 3, 2022
August 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The residual myometrial thickness at 3 months by trans vaginal us.
Evaluation of the residual myometrial thickness at 3 months after the caesarean section by trans vaginal ultrasonography saline infusion sonohystrography will be done ( in a full bladder patients , Casco speculum will be inserted into vagina followed by insertion of soft non balloon tip catheter 5 French into uterus through vagina then cervix. The speculum was extracted to insert the transducer, 5-10 cc of saline was inserted through the catheter into the uterine cavity to allow the lining of the uterus to be imaged clearly on the ultrasound screen and showed any endometrial abnormality,. Residual myometrial thickness "RMT" is the distance between the tip of the hypo echoic triangle and the surface of anterior uterine wall measured by mm.)
3 months
Study Arms (2)
o Group (1): 30 cases who will undergo Two Layer Uterine Closure
o After the delivery the first group will undergo Two Layer Uterine Closure: Double-layer closure of the uterine incision will be performed using unlocked continuous Polyglactin thread sutures(1/0) for both layers, with a large portion of the myometrium and the endometrium included in the first layer. The second layer was a continuous running suture that imbricate the first layer, including serosal and myometrial tissue.
o Group (2): 30 cases who will undergo single layer uterine closure.
The second group will undergo continuous unlocked sutures in a single layer, Uterine closure will begin from one corner of the incision and then the uterine incision wound is closed using Polyglactin thread include endometrium, myometrium and serosa
Interventions
After the delivery the first group will undergo Two Layer Uterine Closure: Double-layer closure of the uterine incision will be performed using unlocked continuous Polyglactin thread sutures(1/0) for both layers, with a large portion of the myometrium and the endometrium included in the first layer. The second layer was a continuous running suture that imbricate the first layer, including serosal and myometrial tissue. The second group will undergo continuous unlocked sutures in a single layer, Uterine closure will begin from one corner of the incision and then the uterine incision wound is closed using Polyglactin thread include endometrium, myometrium and serosa.
Eligibility Criteria
Randomization will be done using computer generated random sequence. Study population will be randomized into one of the two groups: * Group (1): 30 cases who will undergo Two Layer Uterine Closure (A) * Group (2): 30 cases who will undergo single layer uterine closure (B)
You may qualify if:
- Singleton pregnancy.
- Gestational age between 37 completed weeks to 42 weeks.
- Patients undergoing elective primary caesarean section.
You may not qualify if:
- Pregnant women who declined to participate.
- History of uterine surgery (e.g. hysterotomy, myomectomy, perforation, caesarean section).
- Presence of maternal disease (diabetes mellitus, connective tissue disorders, uterine malformations).
- Women Diagnosed with Placenta Accreta Spectrum during the current pregnancy
- Multiple pregnancy.
- Chorioamnionitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sara abdelrazik Ramadan hamad
Cairo, Egypt
Study Officials
- STUDY DIRECTOR
Mohamed Hamed, Asst . Prof
Ain Shams Maternity Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- The principal investigator
Study Record Dates
First Submitted
March 3, 2022
First Posted
March 11, 2022
Study Start
April 20, 2022
Primary Completion
October 20, 2022
Study Completion
April 1, 2023
Last Updated
August 16, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share